Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
46.97
-0.68 (-1.43%)
Dec 26, 2025, 4:00 PM EST - Market closed
Vaxcyte Market Cap
Vaxcyte has a market cap or net worth of $6.15 billion as of December 26, 2025. Its market cap has decreased by -45.45% in one year.
Market Cap
6.15B
Enterprise Value
4.52B
1-Year Change
-45.45%
Ranking
Category
Stock Price
$46.97
Market Cap Chart
Since June 15, 2020, Vaxcyte's market cap has increased from $1.38B to $6.15B, an increase of 345.57%. That is a compound annual growth rate of 30.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 6.15B | -39.74% |
| Dec 31, 2024 | 10.20B | 70.74% |
| Dec 29, 2023 | 5.98B | 57.79% |
| Dec 30, 2022 | 3.79B | 201.58% |
| Dec 31, 2021 | 1.26B | -7.24% |
| Dec 31, 2020 | 1.35B | -1.90% |
| Jun 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.53B |
| Johnson & Johnson | 495.78B |
| AbbVie | 404.36B |
| UnitedHealth Group | 294.22B |
| AstraZeneca | 287.19B |
| Novartis AG | 267.64B |
| Merck & Co. | 260.71B |
| Novo Nordisk | 232.28B |